| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Gamida Cell Ltd. | Director | Ordinary Shares | 242K | $375K | $1.55 | 31 Jan 2024 | Direct |
| Allovir, Inc. | Director | Common Stock | 70K | $55.5K | $0.79 | 06 Jun 2024 | Direct |
| 4D Molecular Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 22.5K | 17 Jun 2025 | Direct | ||
| Cabaletta Bio, Inc. | Director | Stock Option (Right to Buy) | 22K | 09 Jun 2025 | Direct | ||
| Gamida Cell Ltd. | Director | Share Option (Right to Buy) | 17K | 19 Oct 2023 | Direct | ||
| UroGen Pharma Ltd. | Director | Stock Option (right to buy) | 10K | 07 Jun 2021 | Direct | ||
| TCR2 THERAPEUTICS INC. | Director | Stock Option (Right to Buy) | 0 | $0.74 | 01 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| FDMT | 4D Molecular Therapeutics, Inc. | 17 Jun 2025 | 1 | $0 | 4 | Director | 20 Jun 2025, 16:04 |
| CABA | Cabaletta Bio, Inc. | 09 Jun 2025 | 1 | $0 | 4 | Director | 09 Jun 2025, 20:17 |
| CABA | Cabaletta Bio, Inc. | 19 May 2025 | 4 | $0 | 4 | Director | 19 May 2025, 21:38 |
| ALVR | Allovir, Inc. | 06 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 16:05 |
| CABA | Cabaletta Bio, Inc. | 03 Jun 2024 | 1 | $0 | 4 | Director | 04 Jun 2024, 19:14 |
| FDMT | 4D Molecular Therapeutics, Inc. | 21 May 2024 | 1 | $0 | 4 | Director | 23 May 2024, 20:45 |
| GMDA | Gamida Cell Ltd. | 31 Jan 2024 | 1 | $0 | 4 | Director | 02 Feb 2024, 16:45 |
| GMDA | Gamida Cell Ltd. | 19 Oct 2023 | 1 | $0 | 4/A | Director | 20 Oct 2023, 16:39 |
| GMDA | Gamida Cell Ltd. | 19 Oct 2023 | 2 | $0 | 4/A | Director | 20 Oct 2023, 16:38 |
| CABA | Cabaletta Bio, Inc. | 21 Jul 2023 | 1 | $0 | 4 | Director | 24 Jul 2023, 08:26 |
| CABA | Cabaletta Bio, Inc. | 21 Jul 2023 | 0 | $0 | 3 | Director | 24 Jul 2023, 08:24 |
| TCRR | TCR2 THERAPEUTICS INC. | 01 Jun 2023 | 4 | $0 | 4 | Director | 01 Jun 2023, 16:32 |
| FDMT | 4D Molecular Therapeutics, Inc. | 23 May 2023 | 1 | $0 | 4 | Director | 25 May 2023, 19:39 |
| ALVR | Allovir, Inc. | 11 May 2023 | 1 | $0 | 4 | Director | 12 May 2023, 17:00 |
| GMDA | Gamida Cell Ltd. | 20 Mar 2023 | 1 | $0 | 4 | Director | 22 Mar 2023, 16:34 |
| GMDA | Gamida Cell Ltd. | 08 Feb 2023 | 2 | $0 | 4 | Director | 10 Feb 2023, 18:30 |
| TCRR | TCR2 THERAPEUTICS INC. | 15 Dec 2022 | 1 | $0 | 4 | Director | 19 Dec 2022, 16:10 |
| GMDA | Gamida Cell Ltd. | 18 Nov 2022 | 2 | $0 | 4 | Director | 22 Nov 2022, 15:37 |
| GMDA | Gamida Cell Ltd. | 30 Sep 2022 | 1 | $15K | 4 | Director | 04 Oct 2022, 16:39 |
| FDMT | 4D Molecular Therapeutics, Inc. | 23 May 2022 | 1 | $0 | 4 | Director | 25 May 2022, 19:08 |
| ALVR | Allovir, Inc. | 17 May 2022 | 1 | $0 | 4 | Director | 19 May 2022, 16:20 |
| ALVR | Allovir, Inc. | 29 Mar 2022 | 1 | $0 | 4 | Director | 31 Mar 2022, 17:20 |
| ALVR | Allovir, Inc. | 29 Mar 2022 | 0 | $0 | 3 | Director | 31 Mar 2022, 17:18 |
| GMDA | Gamida Cell Ltd. | 01 Jan 2022 | 0 | $0 | 3 | Director | 03 Jan 2022, 15:23 |
| TCRR | TCR2 THERAPEUTICS INC. | 09 Dec 2021 | 1 | $0 | 4 | Director | 10 Dec 2021, 15:35 |
| URGN | UroGen Pharma Ltd. | 07 Jun 2021 | 1 | $0 | 4 | Director | 09 Jun 2021, 13:43 |
| FDMT | 4D Molecular Therapeutics Inc. | 17 May 2021 | 1 | $0 | 4 | Director | 19 May 2021, 20:31 |